Free Republic 3rd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $12,693
15%  
Woo hoo!! And now less than $300 to reach 16%!! Thank you all very much!! God bless.

Keyword: interleukin6

Brevity: Headers | « Text »
  • Interleukin-6: a new therapeutic target in systemic sclerosis?

    05/08/2013 3:50:30 PM PDT · by neverdem · 2 replies
    Clinical & Translational Immunology ^ | 12 April 2013 | Steven O'Reilly, Rachel Cant, Marzena Ciechomska and Jacob M van Laar
    Abstract Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells, except lymphocytes and hepatocytes, express the functional membrane IL-6 receptor thus reducing the number of IL-6-responsive cells. Trans-signalling, the shedding of the membrane-bound form of the IL-6 receptor into the local microenvironment, greatly increases the range of cells that can respond. IL-6 has been demonstrated to have a pivotal role in the pathogenesis of rheumatoid arthritis, Castleman’s disease and Crohn’s...